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Yersinia enterocolitica may persist for prolonged periods of time in humans sometimes
resulting in the development of reactive arthritis. To elucidate factors predisposing for per-
sistence we developed animal models. In Lewis and Fischer rats, viable bacteria could be
demonstrated for prolonged time and abscesses could be found in the liver, spleen and lungs.
Splenic abscesses were observed for more than 20 weeks. Yersinia enterocolitica persisted in
Lewis and Fischer rats, but only Lewis rats developed reactive arthritis. In Brown Norway rats
abscesses developed early during infection but in contrast to the other strains disappeared
after 3 weeks. Culture of homogenized abscess-containing tissue of all three rat strains yielded
Yersiniae. Immunofluorescence studies of the abscesses showed diffuse staining inside the
abscesses only, indicating the presence of Yersinia enterocolitica antigen. Brown Norway rats,
in contrast to Lewis and Fischer rats, developed a different serological reaction pattern against
Yersinia enterocolitica antigens and this correlated with the disappearance of the abscesses.
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Introduction
Gastrointestinal infection with Yersinia enterocolitica is self-limiting in most cases
because the host’s inflammatory response is usually able to eliminate the bacteria.
In some cases infection with Y. enterocolitica as well as infection with a variety of
micro-organisms, such as Salmonella and Chlamydia1,2 may lead to the development
of a persistent infection with or without the ensuing development of sequellae such
as reactive arthritis. It is unknown why some people develop such a chronic infection
whereas others do not. Persistence of the causative organism or bacterial antigens
somewhere within the body, thereby maintaining a stimulus for a prolonged immune
response and inflammation, might explain the persistence of Y. enterocolitica-speci-
fic IgA antibodies in patients with chronic infection or Y. enterocolitica-associated
reactive arthritis.3,4 A prerequisite for the development of reactive arthritis seems to
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be the persistent presence of bacteria or bacterial antigens in the body.4–7 Typically,
no bacteria can be cultured from affected joints which separates reactive arthritis
from septic arthritis. However, bacterial antigens (immune-complexes) have been
demonstrated.5,7 In addition, the majority of patients developing reactive arthritis as
well as other spondylarthropathies have the MHC class I antigen typing of HLA-B27.8–11
Persistent Y. infection in animal models followed by the development of reactive
arthritis has been described previously. Lewis and spontaneously hypertensive (SHR)
rats6,12–15 as well as several strains of mice16 develop arthritis after infection with Y.
enterocolitica. Here we describe and compare a new rat model that might provide
useful information to study the pathogenesis of persistent Y. enterocolitica infections
and ensuing sequellae.
Results
Characteristics of Y.enterocolitica infection in different rat strains
Lewis rats. Two weeks after inoculation with Y. enterocolitica multiple macroscopic
abscesses were found in the spleen of all animals. In some of the animals abscesses
were also found in the liver (40%) and lungs (13.3%). Yersiniae were recovered from
all abscesses. Liver and lungs without macroscopic visible abscesses (i.e. day 7 after
infection) also yielded positive cultures. Internal organs from uninfected rats as well
as blood and Peyer’s patches from infected rats did not contain any viable Yersiniae.
Splenic abscesses persisted for more than 138 days and reached maximal sizes
of 3.5 cm diameter. Throughout this period Yersiniae could be cultured from the
abscesses. Abscesses in liver and lungs disappeared 5 to 6 weeks after infection and
these organs became culture negative.
Microscopic examination of splenic tissue revealed abscesses encapsulated with
a thick fibroblastic layer (Fig. 1A). Infiltration of granulocytes was a prominent feature
(a) (b)
Fig. 1. Spleen of Lewis rat with large abscess 5 weeks after i.v. infection with 104 cfu Yersinia entero-
colitica O : 8WA (5 mm section). (a) hematoxylin-eosin stain; (b) immunofluorescence. a = abscess, f =
fibroblast capsule, s = normal splenic tissue. Bar represents 25 mm.
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Fig. 2. Peyer’s Patch of Lewis rat 2 weeks after i.v. infection with 104 cfu Yersinia enterocolitica O : 8WA.
Toluidine Blue stain (1 mm section). Notice proliferation of lymphatic tissue (L). Bar represents 25 mm.
of the abscesses, however intact bacteria could not be distinguished. Immuno-
histological staining of the splenic tissue revealed strong, diffuse fluorescence within
the abscesses (Fig. 1B). No fluorescence was observed in the fibroblastic layer or in
the unaffected splenic tissue, indicating that bacteria or bacterial antigens are located
inside the abscesses. As in the spleen, immunofluorescence of liver sections was
confined to abscesses (results not shown). Although no bacteria could be dem-
onstrated within the Peyer’s patches, histological examination revealed proliferation
of lymphatic tissue (Fig. 2).
Serum samples taken at sequential timepoints after infection showed the devel-
opment of an antibody response against five outer proteins (Yops) of Yersinia (Yops
O, M, H, D and N) within two weeks after inoculation of bacteria (Fig. 3A). These
antibody levels persisted for more than 138 days.
Three weeks after injection of bacteria 12 out of 15 Lewis rats had developed
arthritis. Swelling of a single, or in two cases both hind paws could be observed. In
the fifth week after infection the swelling began to subside and 2 weeks later no
distinction could be made between rats with and without an episode of arthritis.
Before, during and after the episode of arthritis no bacteria could be cultured from
the affected joints.
Fischer rats. After inoculation of bacteria the same pathology could be observed
in Fischer rats as in Lewis rats with the exception of the development of reactive
arthritis which was absent in Fischer rats. Macroscopic abscesses were found in the
spleen of all animals, and sometimes in liver (33.3%) and lungs (20%). Antibody
reactivity in Fischer rats did not differ from that observed in Lewis rats (Fig. 3B).
Brown Norway rats. In Brown Norway rats abscesses developed in spleen (100%),
liver (20.6%) and lungs (13.3%) and bacteria could be cultured from these organs.
Histology showed the same characteristics as described for Lewis and Fischer rats.
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Fig. 3. Immunoblot of serum from individual rats after infection with Yersinia enterocolitica O : 8WA.
From left to right lanes indicate serum samples taken on day 0, 7, 14, 22 and 35 after infection. A = Lewis
rats, B = Fischer rats, C = Brown Norway rats. Mol. weight Yops: YopO = 84 kD, YopH = 51 kD, YopM = 48 kD,
YopD = 37 kD, YopN = 35 kD, YopP = 30 kD and YopE = 25 kD.
However, after 21 days abscesses decreased in size and all organs became culture
negative.
All Brown Norway rats produced antibodies against Yops O, M, H, D, N and against
two additional Yops, YopP and YopE (Fig. 3C), and this response became prominent
at the time that abscesses began to decrease in size. During the course of the infection
humoral reactivity against Yops O, M, H, D and N ultimately decreases as indicated
by the fading of the immunoblot pattern against these Yops. No reactive arthritis
developed in Brown Norway rats.
Discussion
Humans infected with Y. enterocolitica serotypes O : 3, O : 8 or O : 9 sometimes
develop a chronic infection with persistent levels of antibodies (IgA subclass) against
Yersinia enterocolitica antigens.4 Persistent infection with either of the three sero-
types may be accompanied by the development of sequellae such as reactive
arthritis.17 Studies in rat models have also shown that infection with Y. enterocolitica
may lead to a chronic infection with persistence of the bacteria somewhere within
the affected host.12 Additional evidence for the prolonged presence of bacteria in
infected rats is presented here. After infection, all three rat strains developed splenic
abscesses from which Yersiniae could be cultured. Furthermore, strong immuno-
fluorescence was found inside the abscesses whereas unaffected tissue lacked any
label. This indicates that viable bacteria are located in the abscesses rather than in
normal splenic tissue. Although no bacteria could be demonstrated inside Peyer’s
Patches, proliferation of the lymphatic tissue indicates an inflammatory response.
Yops are strong antigens and elicit a specific IgM-, IgA- and IgG-antibody response
in orally infected rabbits,18 in humans suffering from Yersinia infection19 and in rats.6
We find persistent antibody levels directed against several Yops in infected Lewis
and Fischer rats in contrast to Brown Norway rats where antibody reactivity began
Persistent Yersinia infection in rats 61
to fade from the fifth week of infection and onwards. This might reflect persistence
of bacteria inside the infected host since the vanishing of Yop-specific antibodies in
sera from Brown Norway rats coincided with the disappearance of abscesses and
bacteria. Development of a humoral response against YopP and YopE was found
exclusively in Brown Norway rats and was associated with disappearance of splenic
abscesses. Failure to mount an anti-YopP and/or anti-YopE response by Lewis and
Fischer rats may therefore be correlated with persistence of bacteria suggesting that
YopP and/or YopE may be suitable target-antigens for effective elimination of the
bacteria by the immune system. Furthermore, antibody reactivity against YopE might
render the bacteria susceptible to phagocytosis since YopE is supposed to be
involved in resistance against phagocytosis through depolymerization of the cellular
actin network.20
Differences in kinetics of antibody production against Yops have been shown by
Gaede et al.6 They found a weaker and delayed antibody response against Yops in
Fischer rats compared to Lewis rats after infection with Y. enterocolitica O : 8WA. In
their study Lewis rats developed reactive arthritis whereas Fischer rats did not. Also
in our experiments Lewis rats developed reactive arthritis in contrast to Fischer rats
but no evidence for a delayed antibody response was found in Fischer rats which
make it unlikely that a relatively early antibody response may explain the devel-
opment of reactive arthritis in Lewis rats.
As described by Hill and Yu12 the development of reactive arthritis after infection
of rats with Y. enterocolitica O : 8WA is closely linked to the prolonged presence of
the causing organism somewhere in the affected host. In their experiments Lewis
rats developed a persistent infection in the spleen followed by arthritis whereas
Fischer rats cleared the bacteria from spleen and liver within 2–3 weeks and did not
develop arthritis. They indicated that the persistence of bacteria in Lewis rats might
be the reason for the development of reactive arthritis. In addition, experiments with
SHR rats15 suggested that the development of arthritis depended on persistence of
the bacteria in the affected host. However, in our experiments Lewis as well as
Fischer rats developed a persistent infection but only Lewis rats developed reactive
arthritis. The reason why in our experiments Lewis rats developed reactive arthritis
and Fischer rats did not still remains unclear since Yersinia persisted in both rat
strains. As described in human reactive arthritis the genetic background (MHC type)
may play a role.9 However, SHR (Spontaneously Hypertensive Rats) and WKY rats
(Wistar Kyoto, the normotensive strain of SHR) that share the same histocompatibility
antigens, differ in their susceptibility to Y. enterocolitica-induced arthritis.13 Further-
more, the microbial status of the host may play a role as described by Gripenberg-
Lerche and Toivanen.21,22 This indicates that the development of reactive arthritis
following a persistent infection with Y. enterocolitica may depend on the immune-
status rather than on the MHC type which may explain the difference between our
results and those observed by others.6,12
Materials and methods
Experimental animals. Male rats weighing at least 300 g were used in all experiments. Lewis
and Fischer rats were obtained from colonies maintained at the central Animal Laboratory,
University Hospital Nijmegen and Brown Norway rats were obtained from TNO, Rijswijk, The
Netherlands. Rats were housed in plastic cages under specific pathogen free conditions and
received water and food ad libitum. For persistence studies five rats of each strain were used
and the experiment was performed three times.
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Bacteria. Yersinia enterocolitica serotype O : 8WA (ATCC 9610) was used in all experiments.
This strain contains the virulence plasmid. Bacteria were cultured overnight in Brain Heart
Infusion broth (BHI) at 26°C. The concentration of inoculated viable bacterial cells was esti-
mated by colony counts on Columbia blood agar plates.
Infection. For all experiments animals were infected intravenously with approximately 104
cfu in 0.2 ml 0.9% saline.
Individual animals from each rat strain were killed 7, 14, 22, 40 and 138 days after inoculation
with Y. enterocolitica. Spleen, liver, lungs and Peyer’s patches were examined for the presence
of macroscopic lesions and assayed for live bacteria. Abscess-containing tissue samples were
prepared for histology.
For serological studies five rats of each strain were inoculated with Y. enterocolitica and
serum samples were taken at serial intervals. In three independent experiments samples were
taken on days 0, 7, 14, 22 and 35 after inoculation and were examined for antibody reactivity
against Yops.
Antiserum. New Zealand White rabbits were obtained from colonies maintained at the
Central Animal Laboratory, University Hospital Nijmegen. Rabbits were immunized with Yer-
sinia enterocolitica O : 8WA (ATCC 9610) as described by Hanski et al.22 Briefly, bacteria were
grown overnight at 26°C in BHI broth containing 20 mM calciumchloride and 20 mM sodium-
oxalate. Formaldehyde fixed bacteria (109 cfu in 1 ml saline) mixed with Complete Freund’s
Adjuvants (1: 1) were injected intracutaneously on 10 locations on the back of the rabbits
followed by booster injections with 105 cfu in 1 ml saline mixed with Incomplete Freund’s
Adjuvants (1:1) 2 and 4 weeks later. Eight days after the second booster the animals were
bled by cardiac puncture and the serum was collected and stored at −20°C.
Bacterial culture. Culture of bacteria from homogenized tissue samples of spleen, liver,
lungs and Peyer’s patches was carried out on Columbia blood agar plates and selective CIN
plates (Cefsulodin Irgasan Novobiocin, Oxoid). API 20E or 50SH was used to identify Yersinia
enterocolitica.
Microscopy. Routine histological procedures were used for preparation of tissue samples
for light microscopy. For immunofluorescence, 5 mm cryosections were allowed to dry
overnight and were then incubated with rabbit-anti-Yersinia enterocolitica serum diluted
1: 250 in 0.05% Tween-20 in PBS. After washing twice with PBS/Tween, the sections were
incubated with swine-anti-rabbit antibodies coupled to FITC (Dako A/S, Glostrup, Denmark;
dilution 1: 50 in PBS/0.05% Tween-20). After washing twice, sections were embedded in Gurr
Aquamountant (BDH Laboratory Suppliers, Poole, U. K.) and examined in a fluorescence
microscope.
Serology. SDS-PAGE/Immunoblotting technique24 was used to determine the presence
of antibodies directed against plasmid encoded Yops. Briefly, Yersinia was grown overnight
at 26°C in BHI broth containing 20 mM MgCl2 and 20 mM EGTA followed by 3 h incubation
at 37°C. After centrifugation released proteins from the supernatant were precipitated with
(NH4)2SO4 and separated by SDS-PAGE followed by Western blotting. Specific antibodies
against Yops were detected by a subsequent incubation of blot strips with rat sera (dilution
1: 250) followed by rabbit-anti-Ig coupled to alkaline phosphatase (1: 500).
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